Type 2 Diabetes | Physician & Payer Forum | South Korea and Taiwan | 2014

South Korea and Taiwan have the most advanced healthcare systems among Asian countries, and both operate a universal health insurance program that covers inpatient and outpatient services as well as pharmaceuticals. Both countries have a high level of pharmaceutical expenditure and an increasing awareness of the financial burden associated to type 2 diabetes which presents a significant opportunity for multinational pharmaceutical companies as the demand for novel antidiabetic drugs continues to grow. In this report, we explore the current market access environment for type 2 diabetes in both countries, and physician and payer attitudes and behaviors concerning currently marketed antidiabetic therapies, and their expectations for emerging therapies.

Login to access report